Long-term stroke and major bleeding risk in patients with non-valvular atrial fibrillation: A comparative analysis between non-vitamin K antagonist oral anticoagulants and warfarin using a clinical data warehouse

INTRODUCTION: Non-vitamin K antagonist oral anticoagulants (NOACs) has been the drug of choice for preventing ischemic stroke in patients with atrial fibrillation (AF) since 2014. Many studies based on claim data revealed that NOACs had comparable effect to warfarin in preventing ischemic stroke wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hancheol, Hong, Jung Hwa, Seo, Kwon-Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923348/
https://www.ncbi.nlm.nih.gov/pubmed/36793489
http://dx.doi.org/10.3389/fneur.2023.1058781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923348/
https://www.ncbi.nlm.nih.gov/pubmed/36793489
http://dx.doi.org/10.3389/fneur.2023.1058781

Ejemplares similares